Loading clinical trials...
Loading clinical trials...
A Long-Term Extension Study Evaluating the Safety and Efficacy of Lorecivivint in Subjects With Osteoarthritis of the Knee
Conditions
Interventions
Placebo
Lorecivivint
Locations
42
United States
Research Site
Tucson, Arizona, United States
Research Site
Anaheim, California, United States
Research Site
Pomona, California, United States
Research Site
San Diego, California, United States
Research Site
Thousand Oaks, California, United States
Research Site
Denver, Colorado, United States
Start Date
August 25, 2020
Primary Completion Date
June 30, 2023
Completion Date
June 30, 2023
Last Updated
December 20, 2023
NCT07364578
NCT06488144
NCT07058623
NCT06083480
NCT06955481
NCT06208631
Lead Sponsor
Biosplice Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions